During the past decade, Soma Clinical Trials conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Soma Clinical Trials" are "NASH - Nonalcoholic Steatohepatitis" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials), "PBC" (1 trials) and "Primary Biliary Cholangitis" (1 trials). Many other conditions were trialed in "Soma Clinical Trials" in a lesser frequency.

Most popular intervention types in "Soma Clinical Trials" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "IVA337" (1 trials), "Tirzepatide" (1 trials) and "Volixibat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Soma Clinical Trials" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Soma Clinical Trials". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Soma Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Soma Clinical Trials, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".